Is CYPHERPUNK TECHNOLOGIES INC. (CYPH) Halal?

NASDAQ Financial Services United States $59M
✗ NOT HALAL
Confidence: 95/100
CYPHERPUNK TECHNOLOGIES INC. (CYPH) is Not Halal under AAOIFI Standard 21 due to its classification in the Asset Management industry, which is excluded under Shariah screening. Companies operating in prohibited sectors such as conventional banking, insurance, alcohol, tobacco, and gambling are automatically excluded regardless of their financial ratios.

Shariah Screening — 5 Standards

Based on financial data from December 2025

Standard Debt Ratio Cash Ratio Receivables Income Status
AAOIFI Excluded — Asset Management ✗ NOT HALAL
DJIM Excluded — Asset Management ✗ NOT HALAL
MSCI Excluded — Asset Management ✗ NOT HALAL
S&P Excluded — Asset Management ✗ NOT HALAL
FTSE Excluded — Asset Management ✗ NOT HALAL

Financial Highlights

P/E Ratio
9.4
EPS
$0.07
P/B Ratio
0.4
EV/EBITDA
-1.2
EV: $45M
Revenue
$0
Beta
-0.1
Low volatility
Current Ratio
35.6

Profitability

Gross Margin 0.0%
Operating Margin 0.0%
Net Margin 0.0%
Return on Equity (ROE) 5.1%
Return on Assets (ROA) -21.6%

Cash Flow & Balance Sheet

Operating Cash Flow-$44M
Free Cash Flow-$141M
Total Debt$38,000
Debt-to-Equity0.0
Current Ratio35.6
Total Assets$163M

Price & Trading

Last Close$0.68
50-Day MA$0.71
200-Day MA$0.70
Avg Volume2.9M
Beta-0.1
52-Week Range
$0.22
$3.70

About CYPHERPUNK TECHNOLOGIES INC. (CYPH)

CEO
Mr. Douglas E. Onsi J.D.
Employees
6
Sector
Financial Services
Industry
Asset Management
Country
United States
Exchange
NASDAQ
Market Cap
$59M
Currency
USD

Cypherpunk Technologies Inc., a privacy technology company, implements a digital asset strategy anchored by Zcash in the United States. The company is involved in identifying, developing, investing in, acquiring, and building privacy-enhancing technologies; and accumulating digital assets, such as ZCash. It also develops biomarker-targeted antibody therapies for patients with cancer and other diseases comprising DKN-01, a monoclonal antibody that inhibits Dickkopf-related protein 1, which has completed Phase 2 study for the treatment of colorectal cancer; and FL-501, a monoclonal antibody inhibiting the GDF-15 protein, which is in preclinical development to treat cancer cachexia, hyperemesis gravidarum and pregnancy-related nausea and vomiting, and other diseases associated with aging and frailty. The company was formerly known as Leap Therapeutics, Inc. and changed its name to Cypherpunk Technologies Inc. in November 2025. Cypherpunk Technologies Inc. was incorporated in 2011 and is based in Cambridge, Massachusetts.

Related Halal Stocks in Financial Services

Frequently Asked Questions

Is CYPHERPUNK TECHNOLOGIES INC. (CYPH) halal to invest in?

Based on our screening using AAOIFI Standard 21 (the strictest methodology), CYPHERPUNK TECHNOLOGIES INC. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.

What is CYPHERPUNK TECHNOLOGIES INC.'s debt ratio?

CYPHERPUNK TECHNOLOGIES INC.'s debt ratio is not available under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%.

What are CYPHERPUNK TECHNOLOGIES INC.'s key financial metrics?

CYPHERPUNK TECHNOLOGIES INC. has a market capitalization of $59M, trailing P/E ratio of 9.4. Return on equity stands at 5.1%.

How often is the screening data updated?

Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.

Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.